Opportunities to Address Clinical Research Workforce Diversity Needs for 2010

147 Pages·2006·0.47 MB·English

by  National Research Council

OPPORTUNITIES TO ADDRESS
CLINICAL RESEARCH
WORKFORCE DIVERSITY NEEDS
FOR 2O1O
Committee on Opportunities to Address
Clinical Research Workforce Diversity Needs for 2010
Committee on Women in Science and Engineering
Policy and Global Affairs
Board on Health Sciences Policy
Institute of Medicine
Jong-on Hahm and Alexander Ommaya, Editors
THE NATIONAL ACADEMIES PRESS
Washington, D.C.
www.nap.edu
THE NATIONAL ACADEMIES PRESS 500 Fifth Street, N.W. Washington, DC 20001
NOTICE: The project that is the subject of this report was approved by the Governing
Board of the National Research Council, whose members are drawn from the councils
of the National Academy of Sciences, the National Academy of Engineering, and the
Institute of Medicine. The members of the committee responsible for the report were
chosen for their special competences and with regard for appropriate balance.
This project was supported by the National Institutes of Health, Grant No. N01-OD-
4-2139, Task Order #142, and the National Academy of Sciences. Any opinions,
findings, conclusions, or recommendations expressed in this publication are those of
the author(s) and do not necessarily reflect the views of the organizations or agencies
that provided support for the project.
International Standard Book Number 0-309-09248-5
Additional copies of this report are available from the National Academies Press,
500Fifth Street, N.W., Lockbox 285, Washington, DC 20055; [phone] or
[phone] (in the Washington metropolitan area); Internet, http://www.nap.edu.
Copyright 2006 by the National Academy of Sciences. All rights reserved.
Printed in the United States of America
The National Academy of Sciences is a private, nonprofit, self-perpetuating society of
distinguished scholars engaged in scientific and engineering research, dedicated to the
furtherance of science and technology and to their use for the general welfare. Upon
theauthority of the charter granted to it by the Congress in 1863, the Academy has a
mandate that requires it to advise the federal government on scientific and technical
matters. Dr. Ralph J. Cicerone is president of the National Academy of Sciences.
The National Academy of Engineering was established in 1964, under the charter of
the National Academy of Sciences, as a parallel organization of outstanding engineers. It
is autonomous in its administration and in the selection of its members, sharing with
the National Academy of Sciences the responsibility for advising the federal govern-
ment. The National Academy of Engineering also sponsors engineering programs aimed
at meeting national needs, encourages education and research, and recognizes the
superior achievements of engineers. Dr. Wm. A. Wulf is president of the National
Academy of Engineering.
The Institute of Medicine was established in 1970 by the National Academy of Sciences
to secure the services of eminent members of appropriate professions in the examina-
tion of policy matters pertaining to the health of the public. The Institute acts under the
responsibility given to the National Academy of Sciences by its congressional charter to
be an adviser to the federal government and, upon its own initiative, to identify issues of
medical care, research, and education. Dr. Harvey V. Fineberg is president of the
Institute of Medicine.
The National Research Council was organized by the National Academy of Sciences
in 1916 to associate the broad community of science and technology with the Academy’s
purposes of furthering knowledge and advising the federal government. Functioning in
accordance with general policies determined by the Academy, the Council has become
the principal operating agency of both the National Academy of Sciences and the
National Academy of Engineering in providing services to the government, the public,
and the scientific and engineering communities. The Council is administered jointly by
both Academies and the Institute of Medicine. Dr. Ralph J. Cicerone and Dr. Wm. A.
Wulf are chair and vice chair, respectively, of the National Research Council.
www.national-academies.org

COMMITTEE ON OPPORTUNITIES TO ADDRESS CLINICAL
RESEARCH WORKFORCE DIVERSITY NEEDS FOR 2010
E. Albert Reece, M.D., Chair, Vice Chancellor and Dean, University of
Arkansas College of Medicine
Rick Martinez, M.D., Director of Medical Affairs, Johnson and Johnson
Nancy E. Reame, Ph.D., Mary Dickey Lindsay Professor of Nursing and
Director, DNSc Program, Columbia University
Sally Shaywitz, M.D., Co-director, Yale Center for the Study of Learning and
Attention, Yale University School of Medicine
Nancy Sung, Ph.D., Senior Program Officer, Burroughs Wellcome Fund
NRC Staff
Jong-on Hahm, Ph.D., Study Director
Elizabeth Briggs, Senior Program Associate
IOM Staff
Alex Ommaya, Sc.D., Senior Program Officer
Michelle Lyons, M.S., Research Associate (until December 2004)
Amy Haas, Senior Program Assistant
v
COMMITTEE ON WOMEN IN SCIENCE AND ENGINEERING
Lilian Wu, Chair, Director of University Relations, International Business
Machines
Lotte Bailyn, T. Wilson Professor of Management, Sloan School of
Management, Massachusetts Institute of Technology
Ilene Busch-Vishniac, Professor, Mechanical Engineering, The Johns
Hopkins University
Ralph J. Cicerone, Former Chancellor, University of California, Irvine (until
January 2005)
Allan Fisher, President and CEO, iCarnegie, Inc.
Sally Shaywitz, Co-director, Yale Center for the Study of Learning and
Attention, Yale University School of Medicine
Julia Weertman, Professor Emerita, Department of Material Science and
Engineering, Northwestern University
Staff
Jong-on Hahm, Director (until October 14, 2005)
Peter Henderson, Acting Director (from October 15, 2005)
Charlotte Kuh, Deputy Executive Director, Policy and Global Affairs
John Sislin, Program Officer
Elizabeth Briggs Huthnance, Senior Program Associate
Amaliya Jurta, Senior Program Assistant (through July 2002)
vi
BOARD ON HEALTH SCIENCES POLICY
Fred H. Gage, Chair, The Salk Institute for Biological Studies, La Jolla,
California
Gail H. Cassell, Eli Lilly and Company, Indianapolis, Indiana
James F. Childress, University of Virginia, Charlottesville
Ellen Wright Clayton, Vanderbilt University Medical School, Nashville,
Tennessee
David R. Cox, Perlegen Sciences, Mountain View, California
Lynn R. Goldman, Johns Hopkins Bloomberg School of Public Health,
Baltimore, Maryland
Bernard D. Goldstein, University of Pittsburgh, Pittsburgh, Pennsylvania
Martha N. Hill, Johns Hopkins University School of Nursing, Baltimore,
Maryland
Alan Leshner, American Association for the Advancement of Science,
Washington, D.C.
Daniel Masys, Vanderbilt University Medical Center, Nashville, Tennessee
Jonathan D. Moreno, University of Virginia, Charlottesville
E. Albert Reece, University of Arkansas, Little Rock
Myrl Weinberg, National Health Council, Washington, D.C.
Michael J. Welch, Washington University School of Medicine, St. Louis,
Missouri
Owen N. Witte, University of California, Los Angeles
Mary Woolley, Research!America, Alexandria, Virginia
IOM Staff
Andrew M. Pope, Director
Amy Haas, Board Assistant
David Codrea, Financial Associate
vii

Preface
Increasing diversity in the U.S. population has sharpened concerns
about the vitality and diversity of the clinical research workforce, concerns that
have persisted for two decades. Our nation’s unprecedented level of invest-
ment in biomedical research has led to an explosion of new knowledge
about human health and disease, but basic research achievements must be
translated into treatments and therapies in order to benefit human health.
This translation requires clinical research conducted by outstanding
scientists, physicians, and other health professionals who understand the
complexities and nuances of health and disease among different population
groups.
Clinical research as an enterprise has traditionally not received the high
level of regard afforded basic research in the research and academic com-
munities, which may be contributing to decreased interest in clinical
research careers among matriculating medical students. This must change
if we are to continue the pace of achievement in translating gains in basic
science to treatment of human disease. All biomedical researchers have a
stake in ensuring that the clinical research workforce thrives and diversifies
for the benefit of human health.
This report has been reviewed in draft form by individuals chosen for
their diverse perspectives and technical expertise, in accordance with proce-
dures approved by the National Academies’ Report Review Committee.
The purpose of this independent review is to provide candid and critical
ix